Disease Detection

Radiomics helps clinicians in finding and segmenting anatomical structures in medical imaging. The radiomics analysis of the segmented areas is subsequently used to quantify the presence of abnormalities and diagnose diseases. Currently, our CE marked COVIA solution is supporting clinicians in the non-invasive diagnosis of COVID-19 lung infection in pandemic circumstances. Furthermore, we are working on different SAMDs to support the detection of HPV+ or hypoxic tumors on CT scans, the detection of HER2+ breast cancer on mammograms and the quantification of regional heterogeneity in PD-L1+ lung cancer on CT scans.
Radiomics disease detection